Genetic studies indicate that chromosome 7q is likely to contain an autism susceptibility locus (AUTS1). We have followed a positional candidate gene approach to identify the relevant gene and report the analysis of four adjacent genes localised to a 800 kb region in 7q32 that contains an imprinted domain: PEG1/MEST, COPG2, CPA1 and CPA5-a previously uncharacterised member of the carboxypeptidase gene family. Screening these genes for DNA changes and association analysis using intragenic single nucleotide polymorphisms (SNPs) provided no evidence for an etiological role in IMGSAC families. We also searched for imprinting mutations potentially implicated in autism: analysis of both DNA methylation and replication timing indicated a normal imprinting regulation of the PEG1/COPG2 domain in blood lymphocytes of all patients tested. The analysis of these four genes strongly suggests that they do not play a major role in autism aetiology, and delineates our strategy to screen additional candidate genes in the AUTS1 locus.
Introduction
Autism is a severe neurodevelopmental disorder characterised by impairments in reciprocal communication and social interaction, accompanied by unusually restricted and stereotyped patterns of behaviours and interests, and an onset in the first three years of life. Twin and family studies have indicated a complex genetic predisposition to this disorder, [1] [2] [3] and several genome scans for autism susceptibility loci have been recently completed. [4] [5] [6] [7] [8] [9] These studies, as well as cytogenetic data, 8, 10 provide evidence that the long arm of human chromosome 7q is likely to contain an autism susceptibility locus (AUTS1).
We are examining candidate genes in this region to investigate their possible etiological role in autism and we report here the analysis of four genes: the mesoderm specific transcript homologue (PEG1/MEST), the gene encoding the coatomer protein complex subunit gamma 2 (COPG2), the gene for carboxypeptidase A1 (CPA1), and a novel gene similar to CPA1, designated carboxypeptidase A5 (CPA5).
PEG1/MEST 11, 12 and COPG2 13 cluster within 7q32. They were selected for investigation because several lines of evidence support a role for imprinted genes in brain function. 14 In addition, some evidence of increased paternal allele sharing in affected sib-pairs and preferential paternal allele transmission to autistic probands has been reported for markers across the region, 8, 15 suggesting the possibility that AUTS1 may show parent of origin-specific effects.
PEG1/MEST was the first imprinted gene mapped to human chromosome 7. The mouse homologue, Peg1/Mest, is widely expressed during embryonic development, particularly in mesodermal tissues, and in areas of the developing brain. 16 Targeted inactivation of the paternally derived Peg1/Mest allele results in embryonic growth retardation and, significantly, Peg1/Mest deficient females show abnormal maternal behaviour, providing evidence for a role of Peg1/Mest in the regulation of mammalian behaviour. 17 Human PEG1/MEST expression has been shown to be imprinted in all fetal tissues. 12 In adult lymphocytes PEG1/MEST is expressed in two different isoforms, having distinctive first exons and differential imprinting status: paternal specific expression is limited to the canonical isoform (isoform 1), while the alternative isoform (isoform A) is biallelically expressed. 18 Monoallelic transcription of PEG1/MEST isoform 1 is paralleled by parent of origin-specific methylation of a CpG island surrounding the first exon of isoform 1. 12 A second imprinted gene, COPG2 (coatomer protein complex subunit gamma 2), was
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recently identified adjacent to PEG1/MEST. 13 The two genes are transcribed in opposite directions and overlap in their 3ЈUTR. Blagitko and colleagues 13 reported paternal specific expression of COPG2 in most fetal tissues, and biallelic expression in fetal brain, liver and adult lymphocytes. COPG2 encodes for the ␥ subunit of the COPI coatomer protein complex, which is involved in vesicle trafficking of proteins from the Golgi complex to the endoplasmic reticulum.
Sequence analysis of the BAC clone djs201/RP11-2E11 (AC007938), containing the entire PEG1/MEST gene, revealed the presence of two genes belonging to the carboxypeptidase A (CPA) family: the first encoding the known pancreatic carboxypeptidase isoform A1 (CPA1), the second encoding a novel CPA isoform. Carboxypeptidases are zinc-containing exopeptidases, catalysing the release of carboxy-terminal amino acids from peptides and proteins. They are synthesised as zymogenes that are activated by proteolytic release of an activation segment. The possible involvement of carboxypeptidases in the pathology of autism is raised by several reports of abnormal patterns of urinary peptides in some individuals with autism. [19] [20] [21] Although these findings have failed to be replicated by other studies and remain controversial, 22 it is possible that altered pancreatic peptidase function could lead to an unusual accumulation of peptides. Furthermore, the presence of CPA gene transcripts has been identified at low levels in extrapancreatic tissues, namely in brain, where they could potentially participate in signalling events such as biosynthesis or inactivation of peptide messengers. 23 To investigate the presence of possible etiological variants in these candidate genes, we screened for DNA changes in their entire coding sequence and intronexon junctions in a group of 48 individuals with autism, selected from those IMGSAC families showing marker allele sharing at the linkage peak on chromosome 7q. To assess the relevance of the identified sequence changes to the autistic phenotype, all variants with potential functional significance were screened in a control sample of 48 non-autistic individuals. In addition, the most frequent polymorphisms and their haplotypes identified through this screening were tested for association with autism in the full IMGSAC family data set.
Imprinted genes disorders, such as Prader-Willi syndrome (MIM 176270), Angelman syndrome (MIM 105830) and Beckwith-Wiedemann syndrome (MIM 130650), are caused in some cases by 'imprinting mutations', which result in incorrect resetting of the parental-specific marks during early gametogenesis, giving rise to silencing of both alleles or double dose expression of imprinted genes. 24 The maternal and paternal alleles of imprinted genes are generally distinguished by a differential methylation pattern 25 and asynchronous replication timing. 26, 27 Therefore, we also searched for potential imprinting mutations involved in autism, both by DNA methylation analysis of PEG1/MEST and COPG2 in autistic patients, and by assessing asynchronous replication timing by fluorescent in situ hybridisation (FISH) to interphase nuclei. 28 Nuclei in which the gene has not yet replicated show two single hybridisation spots, whereas nuclei in which the gene has replicated reveal two sets of doublets. In general most gene loci replicate on the two homologous chromosomes in a fairly synchronous manner with only a small proportion of the nuclei showing an asynchronous single/double hybridisation pattern. Probes for imprinted genes show a higher frequency of cells with both a single and a double hybridisation dot compared to non-imprinted genes.
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Materials and methods
Families
The identification of families and assessment methods used by the IMGSAC have been previously described. 15, 29 Briefly, in families passing an initial screen, parents were administered the ADI-R and the Vineland Adaptive Behaviour Scales. Potential cases were assessed using the ADOS or ADOS-G. Physical examination was undertaken to exclude recognisable medical causes, particularly tuberous sclerosis. Karyotyping was performed when possible on all affected individuals and molecular genetic testing for Fragile X performed on one case per family. One family meeting all other criteria was excluded from the study because of a chromosomal abnormality −45, XY, der(13;14) (q10;q10), and one family was excluded because the probands were positive for fragile X.
Characterisation of the CPA5 gene CPA5 exons were predicted based on homology to other CPAs by a BLASTX search of the AC007938 sequence, leading to the identification of 10 potential exons, which did not include the initial exon. The sequence of the first exon was predicted by the Genscan program. We designed a set of nested primers (Table 1 ) from the predicted exons and used them to amplify by RT-PCR the corresponding cDNA from lymphoblastoid cell lines and in a multiple tissue cDNA panel (Clontech, CA, USA, cat No. K1420-1). RNA was extracted from lymphoblastoid cell lines of two normal individuals with Trizol reagent (GIBCO Life Technologies, The Netherlands) according to the manufacturer's instructions. Five g of total RNA was subjected to reverse transcription using Superscript RT kit (GIBCO Life Technologies) and random hexamers. Reactions with no reverse transcriptase were performed as controls. Five per cent of the RT reaction or 2 l of cDNA from the Clontech panel were used for PCR, under the following conditions: 2.5 mM MgCl 2 , 0.2 mM dNTPs, 0.4 M primers, 0.25 U Taq Gold Polymerase (Applied Biosystems, USA) in standard KCl buffer, and a 'touch-down' protocol (10 cycles of 30 s at 95°C, 30 s at T1-0.5°C per cycle, 45 s at 72°C, followed by 20 cycles of 30 s at 95°C, 30 s at T2, 45 s at 72°C). PCR products were gel-purified using Qiagen Gel Extraction kit and directly sequenced on both strands with Big Dye Terminator kit (Applied Biosystems) on an ABI-PRISM 377 semi-automated sequencer. Mutation screening by DHPLC PCR amplifications were performed in a final volume of 50 l containing 40 ng of genomic DNA extracted from blood, 1.5-2.5 mM MgCl 2 , 0.2 mM dNTPs, 0.2 M each primer and a mixture of 0.9 U Taq Gold Polymerase and 0.05 U Pfu Turbo DNA Polymerase (Stratagene, UK) in a standard KCl buffer. For GC-rich regions PCR reactions were performed with the addition of 5% DMSO and 100 M 7-deaza-2Ј-deoxyguanosine-5Ј-triphosphate (Amersham Pharmacia Biotech, UK). Thirty-nine cycles were performed with a touch-down protocol (14 cycles of 30 s at 95°C, 30 s at T1-0.5°C per cycle, 30 s at 72°C, followed by 25 cycles of 30 s at 95°C, 30 s at T2, 30 s at 72°C). Primers for PEG1/MEST, CPA1 and CPA5 were designed using the program Primer 3 (http://www.genome.wi. mit.edu/cgi-bin/primer/primer3Fwww.cgi), while for COPG2 we used the same primers described by Blagitko et al. 13 Sequences and PCR conditions of all primer pairs are available from the IMGSAC web site (http://www. well.ox.ac.uk/ෂmaestrin/iat.html).
DHPLC analysis was carried out using the WAVE  DNA Fragment Analysis System (Transgenomic, UK). Crude PCR products were subjected to denaturation at 95°C for 4 min followed by gradual reannealing from 95°C to 25°C over 35 min, and were injected into a DNASep R Column. The column mobile phase consisted of a linear acetonitrile gradient in a 0.1 M triethylamine acetate buffer (TEAA), achieved by mixing of buffer A (0.1 M TEAA) and buffer B (25% acetonitrile in 0.1 M TEAA). All the gradients and the relative temperature(s) for the elution of the fragments were designed using the WAVEMaker 3.4 program. The calculated gradient at a flow rate of 0.9 ml min −1 was run for all the amplicons at the relevant column temperature(s) for each fragment.
Samples showing a variant DHPLC pattern were sequenced to determine the nature of the heterozygous
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change. In all cases where a non-synonymous substitution was detected (CPA1 ex6, CPA4 ex3, and CPA4 ex8), the corresponding fragment was further examined in all 48 autistic subjects and a control group of 48 Caucasian individuals by sequencing, to compare the variant's frequency in the two samples.
Genotyping of SNPs and microsatellites
The three SNPs COPG2 ex17, COPG2 int20, and CPA1 ex3 were genotyped by restriction digestion using the enzymes BsaI, BseRI, ApaI, respectively. The SNPs PEG1-int2, PEG1 3ЈUTR and CPA5 ex3a could not be distinguished by a commercial restriction enzyme, therefore we designed the following mismatch primers using the program CRFLP (kindly provided by Prof Hongua Li, University of Medicine and Dentistry, NJ, USA): 5ЈCATTTTAATGTCAATTTGGTCAC3Ј and 5ЈTCTCTGGACTTCCAACCACACC3Ј for PEG1-int2 creating a PvuII site, 5ЈCTGTATTACCTCCCCTACT CCCTTA3Ј and 5ЈAGCTCCTGCTGGCTTCTTCCTA3Ј for PEG1 3ЈUTR creating a NdeI site, 5ЈAGGA TTGTGTGGAAGGACATGGAG3Ј and 5ЈGATAAGC TTTGATGTCTTTCAGTCC3Ј for CPA5 ex3a, creating a BspEI site.
Crude PCR products were digested in a 20-l reaction with the appropriate enzyme (New England Biolabs), according to the manufacturer's instructions. Fragments were separated on 3:1 NuSieve GTG agarose (FMCBioproducts, USA)/standard agarose gel. The PAC clone 144H10 was obtained from the RCPI Human PAC library (Research Genetics). By STS analysis we determined that it contains the genomic sequence spanning CPA1 exon 4 to the 3Ј end of PEG1/MEST. Two dinucleotide repeat polymorphisms, named M144CA1AC and M144CA2DB, were isolated from the PAC by subcloning and hybridisation to a labelled CA repeat probe. The following primers were designed to amplify these markers from genomic DNA: 5ЈTCT GCATGTTCCTGATTGGG3Ј, 5ЈCACACATCAAAAAC CCATGG3Ј (M144CA1AC); 5ЈGACACAGAAGAG CCCAGCAA3Ј, 5ЈTCACAAATTAAACTTTATCAT GGGTC3Ј (M144CA2DB). The two microsatellites are localised between the CPA1 and PEG1/MEST genes at the following distances: CPA1 −19 kb-M144CA1AC −51 kb-M144CA2DB −33 kb PEG1/MEST. Genotyping was performed on ABI sequencing machines as described previously. 4 For each marker genotyping was successful in over 90% of the individuals.
Association analysis
The 169 IMGSAC multiplex families used for association analysis have been described elsewhere. 15, 29 Briefly, the data set included 146 sibling pair families contributing 152 sib-pairs, and 23 other extended relative-pair families, for a total of 341 affected individuals.
Transmission disequilibrium testing (TDT) 30 was performed using the sib tdt program from the ASPEX package. 31 This program calculates probabilities for chi-squared statistics by permuting parental alleles whilst fixing the IBD status of siblings within a family, thereby allowing the use of multiple siblings within a nuclear family; this is a valid test for association in the presence of linkage. For the 23 extended relative-pair families, only one affected individual was included in the analysis. Sex-specific TDT was carried out using the 'sexFsplit' option. TDT analysis of two-point and three-point multilocus haplotypes of flanking markers was performed using the TDTPHASE program; 32 empirical probabilities were calculated on 1000 replicates and the 'tsu' option was used to apply a correction for linkage in sib-pairs. 33 
Cloning and sequencing of COPG2 promoter region
The BAC clone DJ972012 containing the COPG2 gene and promoter region was isolated from the BAC RPCI-5 library (obtained from the YAC Screening Centre, DiBiT, Milan, Italy) by PCR screening, utilising COPG2 exon-1 specific primers. A restriction map of the 5Ј region of the gene was obtained by digestion of the BAC with several restriction endonucleases, followed by Southern blot hybridisation with an exon-1 specific probe. A 6-kb EcoRI/PvuII fragment containing the promoter region and exon-1 was cloned into EcoRI/SmaI digested pBluescript SK II+, and sequenced on both strands by primer walking (GenBank accession number AF324497).
Methylation analysis
The mat-UPD7 cell line was obtained from Coriell Cell Repositories (GM11496). Seven g of DNA from 46 patient and 10 control blood DNA samples were digested with the restriction endonucleases EcoRI and HpaII, or EcoRI and MspI. MspI and HpaII recognise the same sequence but HpaII does not cut in the presence of methylation. Therefore, the methylation status of a sequence can be inferred by comparison of their restriction pattern. The digested samples were fractionated on a 1% agarose gel and transferred to a Hybond N+ nylon membrane, using a standard protocol. Probes were labelled using the Megaprime DNA Labelling System (Amersham Pharmacia Biotech) and hybridised in 5 × SSPE, 5X Denhardt's, 2% SDS, 0.5 mg ml −1 yeast RNA, for 20 h, at 65°C. The filters were washed in 0.2 × SSC, 0.1 SDS%. The same filters were successively hybridized to the probes described below. The PEG1/MEST probe was obtained by PCR amplification of a control genomic DNA using primers AGTCTGCCCACTTGATCCAT and TGGCCCCTAA-TAAATACTGCTT. For COPG2, probe A was obtained by EcoRI/PstI digestion of the 6-kb subclone described above. Probe B was obtained by subcloning an EcoRI/PstI fragment from the BAC DJ972012.
Replication timing analysis
Replication analyses were performed on phytohaemoagglutinin (PHA) stimulated T lymphocytes prepared for karyotypic analysis. 34 PAC clone 144H10 (RCPI Human PAC library, Research Genetics) containing the sequence for MEST/PEG1, cosmid clone ICRFc113M216Q1 containing the sequence for COPG2 and chromosome 9 BAC clone 273N4 (RPCI-11 Human BAC Library, Research Genetics) were directly labelled with SpectrumRed dUTP using Vysis Nick translation kit. A commercial preparation of SpectrumOrange labelled DNA for SNRPN was obtained from Vysis UK Ltd. Slides and probes were prepared for FISH as described. 35 Following post-hybridisation washes, slides were rinsed in PBS and mounted in Vectorshield containing DAPI (4,6-diamidino2-phenyl indole) (Vector Labs, USA) and examined under a Nikon optiphot microscope with appropriate filters.
Interphase cells were scored for three replication patterns: two singlets, a singlet plus a doublet, or two doublets. Since singlets in late replicating BAC and PAC probes can also produce hybridisation signal as clusters of two or three dots of reduced intensity, interphase cells showing this phenomenon were not scored. Where possible a minimum of 50 cells were scored.
Data accession
Sequence data from this article have been deposited with the EMBL/GenBank Data Libraries under Accession No. AF324497 and AF384667.
Results
Characterisation and genomic structure of the carboxypeptidase A genes
The CPA1 gene was localised adjacent to PEG1/MEST in the BAC clone djs201/RP11-2E11 (AC007938) by BLAST analysis. The intron-exon organisation of CPA1 was obtained by comparison of the cDNA sequence with the genomic sequence of clone djs201.
The CPA2 gene was previously reported to map in the genomic region just proximal to CPA1. 36 Sequence analysis of the djs201 BAC clone predicted the presence of a gene similar to CPA1, however distinct from CPA2. This gene corresponds to a novel CPA isoform, which we designated CPA5. By searching the EST database we found several ESTs belonging to the Unigene cluster Hs.144699 identical to the 3Ј end of the CPA5 gene. The complete coding sequence of CPA5 was deduced by homology to other CPAs and through exon prediction programs and was confirmed by RT-PCR amplification and sequencing of the resulting fragments ( Figure 1) . CPA5 is composed of 11 exons, its intron-exon structure is conserved with the human and rat CPA1 and CPA2 genes, except that both human CPA5 and rat CPA2 contain an extra intron dividing the third exon into two parts (exons 3A and 3B). Comparison of the translated sequence of CPA5 with other known metallocarboxypeptidases showed the greatest similarity to human CPA1 (60.3% amino acid identity), followed by CPA2 (53.8%) and CPA4 (51.2%).
CPAs exist as procarboxypeptidases with a structure containing an amino-terminal signal peptide, an activation segment, and a carboxypeptidase domain. As shown in Figure 2 , CPA5 shares significant structural similarity with other members of the CPA family. All residues known to be important in zinc binding, substrate anchoring and positioning, and catalysis are conserved. The amino terminal region of the deduced CPA5 protein is longer compared to other CPAs and was predicted to be a signal peptide by computer analysis programs (SigCleave and SignalP 37 ). The expression of CPA5 was studied by RT-PCR on a multiple tissue cDNA panel. CPA5 was found to be expressed at low levels in all human tissues examined, including brain, kidney, liver, pancreas, placenta and skeletal muscle. Hybridisation to a Clontech Multiple Tissue Northern Blot containing RNA from heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas was performed using a probe from the 3Ј untranslated (3ЈUTR) region with low homology to other CPAs, but no signal was detected, suggesting that CPA5 is a rare transcript in most human tissues.
Mutation screening
Forty-eight unrelated individuals with autism from the IMGSAC family collection were screened for sequence variants using Denaturing High Performance Liquid Chromatography (DHPLC). 38 The patients were selected from affected sib-pair families on the basis of sharing either one or two alleles identical by descent (IBD) in the region surrounding the candidate genes, based on flanking microsatellite marker analysis. Primers were designed to cover all exons and intron-exon boundaries of the four genes, as well as the putative promoter sequences of PEG1/MEST, COPG2, and CPA1. Genomic DNA from the patients was amplified by PCR and subjected to analysis by DHPLC to identify heteroduplexes. Samples that showed variant DHPLC patterns were reamplified and directly sequenced. We identified a total of 41 sequence variants: four in PEG1/MEST, 14 in COPG2, five in CPA1 and 18 in CPA5 ( Table 2 ). All variants detected in PEG1/MEST and COPG2 are in intronic regions or lead to synonymous substitutions in the translated protein sequence. Four variants detected in CPA1 and CPA5 lead to nonsynonymous substitutions and possibly could have an impact on protein function. The frequency of the four non-synonymous substitutions was compared between the autism sample and a control group of 48 non-autistic subjects (Table 2) . No significant increased frequency was detected in the autism sample, suggesting that these substitutions are neutral polymorphisms rather than etiological variants.
Association analysis
We isolated two microsatellite markers from the PAC clone 144H10 (RCPI Human PAC library, Research Genetics), located in the intergenic region between CPA1 and PEG1/MEST. The two microsatellites and six of the identified SNPs (CPA5-ex3a, CPA1-ex3, PEG1-int2, PEG1-3ЈUTR, COPG2-ex17 and COPG2-int20) were genotyped in 169 multiplex families from the IMGSAC collection and tested for association with autism using the Transmission Disequilibrium Test (TDT). 30 Association was also tested for two-point and threepoint haplotypes of flanking markers. No significant transmission disequilibrium was detected at any of the markers or haplotypes.
Given the possibility of a differential effect of paternal and maternal allele transmissions, we examined transmission according to parental sex. Only COPG2-ex17 showed a trend toward transmission disequilibrium of maternal alleles (36 transmissions vs 19 non-transmissions, P = 0.039). However, given the number of tests performed this result has probably arisen by chance.
Methylation analysis
To test for potential imprinting mutations, leading to an abnormal methylation pattern, we performed DNA methylation studies in the 5Ј CpG island regions of PEG1/MEST and COPG2.
The parent-specific methylation pattern of the 5Ј CpG island of PEG1/MEST has been previously described. 12 The CpG island is unmethylated on the active paternal chromosome and methylated on the maternal chromosome. We performed Southern blot hybridisation using DNA extracted from lymphocytes of 46 individuals with autism from the IMGSAC family collection, and 10 normal controls. Genomic DNA was digested with EcoRI followed by digestion with either GCTAGAAATGTCTGCTCTC  207  35  C→T  4  TACAATGCCTAGGGGAAAG  COPG2 int17  GCTAGAAATGTCTGCTCTC  207  39  G→C  3  TACAATGCCTAGGGGAAAG  COPG2 int18  GCTAGAAATGTCTGCTCTC  207  181  G→A  1 9  TACAATGCCTAGGGGAAAG  COPG2 int20  CTTGCACTCCCCACTGAT  220  38  C→T  2 4  GAAAAATGTTCTCTCAAGGCA  COPG2 int21  CTTGCACTCCCCACTGAT  220  176  ins(G)  3  GAAAAATGTTCTCTCAAGGCA  COPG2 3ЈUTR  CCAGTGCTTGTTTTGGGT  333  271  T→C  1  TGCTTGATCTGCTGGCTC  CPA1 int5  AGGCCTCAGCTGTGAAATTG  498  329  C→G  1  AGAGGCCCATCCTGCTTC  CPA1 int7  CTCTCTGCAGCCTCTGAACC  250  187  C→G  2 8  GAGCAAGAGCAGTGGTGAGG  CPA5 5Ј  TTCCTCCTTCTCTCTTCCCTCT  463  130  T→A  1 4  ATCCTGACTCTCCGCCTTGAT  CPA5 5Ј  TTCCTCCTTCTCTCTTCCCTCT  463  140  T→C  1 4  ATCCTGACTCTCCGCCTTGAT  CPA5 int1  CTTCCAAGTGACACAGCCTTCCAG  226  61  G→A  1  GGCAGGACAAGGAGCTAAATGTGT  CPA5 int2  CTTCCAAGTGACACAGCCTTCCAG  226  198  G→T  7  GGCAGGACAAGGAGCTAAATGTGT  CPA5 int2  CTTCCAAGTGACACAGCCTTCCAG  226  186  C→T  4  GGCAGGACAAGGAGCTAAATGTGT  CPA5 int6  ACACACACCCTCTTACCCAGTGCT  749  444  C→G  8  CTTTTCTCCATCCCCCTAGAGCTG  CPA5 int8  CAGGATATCAGAGGCTCCCATCC  301  270  A→G  1 3  GCCGTGACTCATGCATATTAGCTG  CPA5 int9  GGAAATGTAGGGGAACACACAGGT  397  339  G→A  1 2  ACCCCTGCATTCAGAGTAACAACC  CPA5 int10  TGCTAAATCCATGCTTCTCACCAG  318  252  A→T  1 7  CTGGGTACCACTGTTCACCCTTCT  CPA5 int10  TGCTAAATCCATGCTTCTCACCAG  318  264  T→G  1 
CTGGGTACCACTGTTCACCCTTCT
MspI or its methylation sensitive isoschizomer HpaII.
Using the probe shown in Figure 3 , the unmethylated paternal allele gives rise to a 540-bp band, and the maternal allele gives rise to a 3.9-kb band, due to methylation of the CpG islands and resistance to HpaII digestion. All patients showed a methylation pattern identical to the control DNAs indicating a normal imprinting status of PEG1 (Figure 3 ). The methylation status of an upstream CpG island surrounding the alternative exon corresponding to PEG1/MEST isoform 2 18 was also investigated in DNA of control individuals. HpaII sites in this CpG island appeared unmethylated on both chromosomes (data not shown), in agreement with the biallelic expression of PEG1/MEST isoform 2.
To study the methylation pattern of the COPG2 gene,
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we first subcloned a 6-kb EcoRI-PvuII fragment from the BAC clone DJ972012 containing COPG2 and sequenced the region upstream and downstream of exon 1 (GenBank accession No AF324497). The putative promoter sequence is typical of a CpG island, lacks a TATA and CAAT box and presents several MspI sites. Methylation analysis was performed as described for PEG1/MEST, using two EcoRI-PstI fragments as probes ( Figure 4) ; probe A (4.8 kb) covers the region upstream of exon 1, and probe B (3.4 kb) encompasses exon 1 and part of intron 1. Probe A detected a partially methylated HpaII/MspI site: digestion with MspI + EcoRI resulted in two fragments of 0.9 and 3.6 kb. The same fragments were present in the HpaII + EcoRI digestion as well as the undigested fragment of 4.4 kb, raising the possibility that this site may be differentially methylated on the maternal and paternal chromosome (Figure 4) . Hybridisation of probe A to DNA from a maternal uniparental disomy of chromosome 7 (mat-UPD7) lymphoblastoid cell line 39 revealed the presence of the 3.6-and 0.9-kb bands only, suggesting that this site may be unmethylated on the maternal chromosome and methylated on the paternal chromosome ( Figure  4 ). The rest of the HpaII/MspI sites in the COPG2 CpG island appeared to be completely unmethylated.
Hybridisation of probe A to Southern blots containing DNA from 46 individuals with autism revealed no abnormalities in the methylation pattern compared to controls (Figure 4) .
Replication timing analysis
FISH analysis was perfomed on T lymphocytes from 12 patients and one normal individual, to test for presence of anomalous replication timing of PEG1/MEST and COPG2. Analysis with a probe for a known imprinted gene, SNRPN, and for a genomic region not regulated by imprinting (chromosome 9 BAC clone 273N4) was also performed as internal control. Interphase cells were scored for the presence of single/double (SD) hybridisation dots vs single/single (SS) and double/double (DD) dots. 28 There was an average of 2-6% DD seen in all samples. The average proportion of SD dots detected was 15.1% for PEG1/MEST, 18.9% for COPG2, 15.4% for SNRPN and 5.4% for the chromosome 9 probe. Data for the chromosome 9 probe were not scored in three patients due to poor hybridisation quality. In all cases the proportions of SD detected with PEG1 and COPG2 probes was comparable to those detected for SNRPN, and greater than those revealed by the chromosome 9 control probe ( Figure 5 ).
Discussion
The genetics of autism is complex, probably involving the action of several genes. Linkage studies and cytogenetic data have implicated several regions of interest in genetic susceptibility to autism, the long arm of chromosome 7 being one of the most significant. 15, 40 The region of interest on 7q is very broad; the interval of linkage reported by the IMGSAC 15 (D7S527-D7S2513) covers around 50 Mb and overlaps regions Molecular Psychiatry identified in a number of other studies. At least 190 known genes are contained within this interval. The difficulties in localising the linkage signal to a small interval, a common problem in nonparametric linkage studies of complex disorders, 41 make the identification of the susceptibility gene in the 7q locus a challenging task, and a combination of approaches may be necessary to achieve this goal.
In an attempt to refine the location of the disease locus the IMGSAC is following a linkage disequilibrium (LD) mapping strategy, by testing a dense grid of polymorphic markers throughout the 7q22-7q34 region for association with the disease. 15 Linkage disequilibrium (LD) mapping can provide a tool to further refine the location of a disease locus, by effectively exploiting historic recombination events in a population. However, at this stage it is not possible to predict whether LD will be detectable between the susceptibility gene and nearby polymorphisms, as this may be hampered by a high degree of allelic complexity or by other factors, such as the age of the etiological variant, markers frequency, population history, and region-specific recombination rates. Since we can not completely rely on LD mapping to define the susceptibility locus, we simultaneously undertook a complementary positional candidate approach, scanning individual candidate genes in the AUTS1 locus for genetic variation and assessing their relevance to autism.
In this paper we report a detailed analysis of the first four candidate genes examined by the IMGSAC, localised to a region in 7q32 containing an imprinted domain, close to the maximum peak of linkage originally reported by the IMGSAC. 4 PEG1/MEST, COPG2 and CPA1 were previously known genes, while CPA5, a novel member of the carboxypeptidase family, has been characterised in this study.
Our mutation screening targeted gene regions most likely to harbour functionally significant variants (coding sequences, intronic regions critical for splicing, and putative promoters). The screening was carried out in a sample of 48 unrelated individuals with autism chosen from the subgroup of IMGSAC families contributing to the linkage peak on 7q, thereby selecting for individuals who are more likely to carry etiological variants at this locus. Using DHPLC, a very sensitive method for mutation scanning, we presumably identified the near totality of DNA variants present in our autism sample. Our DHPLC screening method would have missed variants which are exclusively present in homozygous individuals and not in heterozygotes, however, we considered this an unlikely event.
We identified several sequence changes, the majority being in non-coding regions or leading to synonymous substitutions. Four non-synonymous substitutions were identified in CPA1 and CPA5, and all of them were also found in a control group of non-autistic individuals at a similar frequency. Accordingly, the corresponding amino-acids are in non-conserved positions in the family of zinc-carboxypeptidase proteins, suggesting that these changes have no major impact on the protein function. We can not exclude that the remaining DNA changes with no apparent functional significance could play a role in autism susceptibility by subtly affecting gene expression or regulation. To investigate this possibility, the most informative SNPs identified through our screen, as well as two microsatellite markers, were tested for presence of association with autism in the total collection of 169 IMGSAC multiplex families. This sample size should be sufficient to detect a locus with a small effect: it can be calculated 42 that a sample size of 130-160 affected sib-pairs would provide 80% power at the 10 −5 significance level to detect a locus having a genotypic risk ratio of 2 and a moderate allele frequency (P = 0.1-0.4), assuming a fully informative and closely linked marker and a multiplicative model. No significant results were detected with single markers or haplotypes, indicating that these polymorphisms do not influence susceptibility, nor are they in LD with the actual causal variation.
Moreover, previous reports have suggested a paternal effect in the AUTS1 locus. 15 , 43 We could not detect sexspecific transmission disequilibrium, suggesting that the genes tested here do not display a parent of originspecific effect. The trend toward preferential transmission of maternal alleles observed for a SNP in COPG2 is likely to have arisen by chance and is in contrast to the putative paternal expression of COPG2 transcripts. The PEG1/MEST gene is paternally expressed in human fetal tissues as a result of genomic imprinting. Monoallelic expression of PEG1/MEST has been shown to be correlated to maternal specific methylation of a CpG island surrounding exon 1. 12 The COPG2 gene has also been reported to be a maternally imprinted gene. 13 However, a more recent study, published during the course of this work, 44 demonstrated biallelic expression of COPG2 in all tested fetal and adult tissues, while an antisense transcript in COPG2 intron 20 (CIT1) was found to be paternally expressed in fetal tissues. These data indicate the presence of additional imprinted transcripts in the region adjacent to PEG1/MEST, but argue against monoallelic expression of COPG2. We have characterised the promoter region of the COPG2 gene containing a CpG island; in lymphocyte DNA we identified an upstream HpaII site likely to be unmethylated on the maternal chromosome and methylated on the paternal chromosome. The parent of origin-specific methylation of this site could be correlated to the monoallelic expression of the CIT1 transcript, or of another imprinted transcript not yet characterised. Methylation studies of the critical CpG island upstream of PEG1/MEST and of the 5Ј region of COPG2 in lymphocyte DNA from 46 individuals with autism showed methylation patterns identical to those of control DNA. Similarly, replication timing analysis in 12 patients revealed that the genomic region containing PEG1/MEST and COPG2 exhibits a replication pattern typical of imprinted genes. Taken together, our data indicate normal imprinting regulation of the PEG1/COPG2 domain in lymphocytes of the tested individuals. Although the possibility of imprinting abnormalities in tissues other than blood can not be excluded, our data suggest that imprinting mutations of the PEG1 domain are not frequently found in autism.
In conclusion, the lack of sequence variants that could be related to the autistic phenotype in the four genes PEG1, COPG2, CPA1 and CPA5, together with the absence of obvious abnormalities in the regulation of imprinting, strongly suggests that these genes do not play a major role in the aetiology of autism. The analysis of additional candidate genes mapping to the 7q locus is currently in progress.
